# Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis

> **NCT05115903** · PHASE4 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 15 (actual)

## Conditions studied

- Axial Spondyloarthritis

## Interventions

- **DRUG:** Tapered doses of TNFi
- **DRUG:** Standard dose of TNFi

## Key facts

- **NCT ID:** NCT05115903
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05115903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05115903, "Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05115903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*